ETH-44

N/A

Report date: 2023/12/08 11:24:42

Base Information

Drug NameETH-44
Drug Alias NameETH-44ETH44
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCiliary Motility Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEthris GmbH
China Registration ClassN/A

Develop Information

Active CompaniesEthris GmbH
Inactive CompaniesN/A
Active IndicationsCiliary Motility Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A